The specific price of Tunlametinib has not been disclosed in public prescribing information. For detailed pricing, please consult formal channels such as hospitals and pharmacies.
This is a prescription drug that must be used under the guidance of a qualified physician. Prior to treatment, NRAS mutation testing is required to confirm the indication.
I. Potential Factors Affecting the Price
Regional differences
Variations in local medical policies and procurement channels may lead to price fluctuations.
Medical insurance policies
Whether the drug is included in the national medical insurance or local reimbursement catalogs will affect the actual out-of-pocket cost for patients.
Dosage and specification
The total cost of a treatment course may vary with dosage adjustments based on the patient’s condition (e.g., 12 mg, 9 mg, or 6 mg twice daily).
Purchase channels
Prices may differ among hospitals, designated pharmacies, or special supply channels.
II. Precautions for Use
Indication limitation
It is only indicated for patients with NRAS-mutated advanced melanoma who have failed prior anti-PD-1/PD-L1 therapy. The mutation status must be confirmed by professional testing.
Adverse reaction management
Potential adverse reactions include cardiac dysfunction, rash, ocular toxicity, etc. Regular monitoring is required; dosage adjustment or drug discontinuation may be necessary depending on severity.
Special populations
Use with caution in patients with moderate to severe hepatic or renal impairment.
Contraindicated in pregnant women, lactating women, and children.
III. Recommendations for Obtaining Price Information
Consult your attending physician
Doctors can provide a personalized treatment plan and cost estimate based on your condition.
Contact the hospital pharmacy
Inquire directly about the current procurement price and medical insurance reimbursement rate.
Follow official channels
Check for updates released by the drug manufacturer or health authorities.
The medication must be used strictly in accordance with medical advice. Do not adjust the dosage or discontinue the drug without authorization to ensure treatment safety and effectiveness.
